Sol-Gel Technologies to host KOL investor event on SGT-610 for Gorlin syndrome
Bitget2026/09/30 13:01- Sol-Gel Technologies will host a KOL investor event on SGT-610 (patidegib gel, 2%) on Oct. 14, 2026 in New York.
- Discussion will focus on Gorlin syndrome disease burden, highlighting the lack of effective therapies.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Morgan Stanley is tactically bullish on BHP (BHP.US): Two major copper mine catalysts may ignite the stock price in the next two months
Morgan Stanley maintains an "Overweight" rating on BHP Group, with an "attractive" industry outlook, and sets a target price of AUD 69.00 for its shares listed in Australia.
Bank of England hawkish official: Growth exceeds expectations and employment is resilient, which precisely proves that further rate hikes are necessary.
Megan Greene, a policymaker at the Bank of England, stated that the UK's economic growth surpassing expectations and the resilience of the job market indicate that the Bank of England's efforts to curb inflation are still insufficient.
24 Hour Crypto Recap: Here’s What Happened in the Market
Crypto prices
More
